Filing Details
- Accession Number:
- 0001246360-14-003064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-26 16:21:09
- Reporting Period:
- 2014-06-25
- Filing Date:
- 2014-06-26
- Accepted Time:
- 2014-06-26 16:21:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559209 | Glen Williams | 33 Hayden Ave Lexington MA 02421 | Svp, Technical Operations | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-25 | 300 | $40.32 | 566 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-06-25 | 400 | $57.56 | 966 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-25 | 700 | $108.02 | 266 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-25 | 300 | $0.00 | 300 | $40.32 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-25 | 400 | $0.00 | 400 | $57.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,700 | 2023-06-06 | No | 4 | M | Direct | |
| 39,600 | 2022-10-04 | No | 4 | M | Direct |
Footnotes
- The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 20, 2014.
- 25% of the total number of shares subject to the option vest and become exercisable on 06/06/2014 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter.
- 25% of the total number of Shares subject to the Option vest and become exercisable on 09/24/2013 and 1/36 of the remainder of the Shares subject to the Option shall vest and become exercisable monthly thereafter.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $108 to $108.03. The price reported in this row reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Billionaire Hedge Funds
